LIVIVO - Search results -

Search results

Result 1 - 10 of total 30

Search options

Article ; Online: Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.

Ray, Bappaditya / Keyrouz, Salah G

2014 Volume 18, Issue 3, Page(s) 223

MeSH term(s)	Anticoagulants/therapeutic use ; Disease Management ; Evidence-Based Medicine/methods ; Humans ; Intracranial Hemorrhages/diagnosis ; Intracranial Hemorrhages/drug therapy ; Intracranial Hemorrhages/epidemiology
Chemical Substances	Anticoagulants
Language	English
Publishing date	2014-05-23
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review
ZDB-ID	2041406-7
ISSN	1466-609X ; 1364-8535
ISSN (online)	1466-609X
ISSN	1364-8535
DOI	10.1186/cc13889
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5517: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Posterior Reversible Encephalopathy Syndrome as a Complication of Induced Hypertension in Subarachnoid Hemorrhage: A Case-Control Study.

Allen, Michelle L / Kulik, Tobias / Keyrouz, Salah G / Dhar, Rajat

Neurosurgery

2018 Volume 85, Issue 2, Page(s) 223–230

Abstract: Background: Induced hypertension (IH) remains the mainstay of medical management for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH). However, raising blood pressure above normal levels may be associated with systemic and ... ...

Abstract	Background: Induced hypertension (IH) remains the mainstay of medical management for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH). However, raising blood pressure above normal levels may be associated with systemic and neurological complications, of which posterior reversible encephalopathy syndrome (PRES) has been increasingly recognized. Objective: To ascertain the frequency and predisposing factors for PRES during IH therapy. Methods: We identified 68 patients treated with IH from 345 SAH patients over a 3-yr period. PRES was diagnosed based on clinical suspicion, confirmed by imaging. We extracted additional data on IH, including baseline and highest target mean arterial pressure (MAP), comparing PRES to IH-treated controls. Results: Five patients were diagnosed with PRES at median 6.6 d (range 1-8 d) from vasopressor initiation. All presented with lethargy, 3 had new focal deficits, and 1 had a seizure. Although baseline MAP (prior to DCI) did not differ between cases and controls, both MAP immediately prior to IH (112 vs 90) and highest MAP targeted were greater (140 vs 120 mm Hg, both P < .01). Magnitude of MAP elevation was greater (54 vs 34 above baseline, P = .004) while degree of IH was not (37 vs 38 above pre-IH MAP). All 4 surviving PRES patients had complete resolution with IH discontinuation. Conclusion: PRES was diagnosed in 7% of SAH patients undergoing IH therapy, most often when MAP was raised well above baseline to levels that exceed traditional autoregulatory thresholds. High suspicion for this reversible disorder appears warranted in the face of unexplained neurological deterioration during aggressive IH.
MeSH term(s)	Adult ; Brain Ischemia/drug therapy ; Brain Ischemia/etiology ; Case-Control Studies ; Female ; Humans ; Hypertension/chemically induced ; Male ; Middle Aged ; Posterior Leukoencephalopathy Syndrome/etiology ; Subarachnoid Hemorrhage/complications ; Subarachnoid Hemorrhage/drug therapy ; Vasoconstrictor Agents/therapeutic use
Chemical Substances	Vasoconstrictor Agents
Language	English
Publishing date	2018-06-07
Publishing country	United States
Document type	Journal Article
ZDB-ID	135446-2
ISSN	1524-4040 ; 0148-396X
ISSN (online)	1524-4040
ISSN	0148-396X
DOI	10.1093/neuros/nyy240
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1424: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 539: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Diffuse leptomeningeal carcinomatosis mimicking brain death.

Kung, Nathan H / Dhar, Rajat / Keyrouz, Salah G

Journal of the neurological sciences

2015 Volume 352, Issue 1-2, Page(s) 132–134

MeSH term(s)	Aged ; Brain Death/diagnosis ; Brain Death/pathology ; Brain Death/physiopathology ; Diagnosis, Differential ; Humans ; Male ; Meningeal Carcinomatosis/complications ; Meningeal Carcinomatosis/pathology ; Meningeal Carcinomatosis/physiopathology
Language	English
Publishing date	2015-05-15
Publishing country	Netherlands
Document type	Case Reports ; Letter
ZDB-ID	80160-4
ISSN	1878-5883 ; 0022-510X ; 0374-8642
ISSN (online)	1878-5883
ISSN	0022-510X ; 0374-8642
DOI	10.1016/j.jns.2015.03.045
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 308: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Year in review 2011: Critical Care--Neurocritical care.

Keyrouz, Salah G / Diringer, Michael N

Critical care (London, England)

2012 Volume 16, Issue 6, Page(s) 245

Abstract: Contributions from the neurosciences to Critical Care in 2011 covered an array of topics. We learned about potential biomarkers for, and the effect of cerebral oxygen metabolism on, delirium, in addition to treatment of the latter. A group of ... ...

Abstract	Contributions from the neurosciences to Critical Care in 2011 covered an array of topics. We learned about potential biomarkers for, and the effect of cerebral oxygen metabolism on, delirium, in addition to treatment of the latter. A group of investigators studied surface cooling in healthy awake volunteers, and incidence of infection associated with therapeutic hypothermia. The effects of statin and erythropoietin on stroke were revisited, and the role of adhesion molecule in the inflammatory reaction accompanying intracerebral hemorrhage was scrutinized. Biomarkers in subarachnoid hemorrhage and their relationship to vasospasm and outcome, and effect of daylight on outcome in this patient population, as well as a new meta-analysis of statin therapy were among the research in subarachnoid hemorrhage. Moreover, 2011 witnessed the publication of a multidisciplinary consensus conference's recommendations on the critical care management of subarachnoid hemorrhage. Results of studies regarding the diagnosis and vascular complications of meningitis were reported. Traumatic brain injury received its share of articles addressing therapy with hypertonic saline and surgical decompression, the development of coagulopathy, and biomarkers to help with prognostication. Finally, research on the treatment of Guillain-Barre syndrome in children, prediction of long-term need of ventilatory support, and pathophysiology of critical illness polyneuropathy and myopathy were reported.
MeSH term(s)	Brain Injuries/therapy ; Critical Care/methods ; Critical Illness/therapy ; Delirium/therapy ; Humans ; Hypothermia, Induced ; Nervous System Diseases/therapy ; Peripheral Nervous System Diseases/therapy ; Stroke/therapy ; Subarachnoid Hemorrhage/therapy
Language	English
Publishing date	2012-12-10
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2041406-7
ISSN	1466-609X ; 1364-8535
ISSN (online)	1466-609X
ISSN	1364-8535
DOI	10.1186/cc11825
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5517: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage.

Pradilla, Gustavo / Ratcliff, Jonathan J / Hall, Alex J / Saville, Benjamin R / Allen, Jason W / Paulon, Giorgio / McGlothlin, Anna / Lewis, Roger J / Fitzgerald, Mark / Caveney, Angela F / Li, Xiao T / Bain, Mark / Gomes, Joao / Jankowitz, Brain / Zenonos, Georgios / Molyneaux, Bradley J / Davies, Jason / Siddiqui, Adnan / Chicoine, Michael R /

Keyrouz, Salah G / Grossberg, Jonathan A / Shah, Mitesh V / Singh, Ranjeet / Bohnstedt, Bradley N / Frankel, Michael / Wright, David W / Barrow, Daniel L

The New England journal of medicine

2024 Volume 390, Issue 14, Page(s) 1277–1289

Abstract: Background: Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known.: ... ...

Abstract	Background: Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known. Methods: In this multicenter, randomized trial involving patients with an acute intracerebral hemorrhage, we assessed surgical removal of the hematoma as compared with medical management. Patients who had a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 ml were assigned, in a 1:1 ratio, within 24 hours after the time that they were last known to be well, to minimally invasive surgical removal of the hematoma plus guideline-based medical management (surgery group) or to guideline-based medical management alone (control group). The primary efficacy end point was the mean score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes, according to patients' assessment) at 180 days, with a prespecified threshold for posterior probability of superiority of 0.975 or higher. The trial included rules for adaptation of enrollment criteria on the basis of hemorrhage location. A primary safety end point was death within 30 days after enrollment. Results: A total of 300 patients were enrolled, of whom 30.7% had anterior basal ganglia hemorrhages and 69.3% had lobar hemorrhages. After 175 patients had been enrolled, an adaptation rule was triggered, and only persons with lobar hemorrhages were enrolled. The mean score on the utility-weighted modified Rankin scale at 180 days was 0.458 in the surgery group and 0.374 in the control group (difference, 0.084; 95% Bayesian credible interval, 0.005 to 0.163; posterior probability of superiority of surgery, 0.981). The mean between-group difference was 0.127 (95% Bayesian credible interval, 0.035 to 0.219) among patients with lobar hemorrhages and -0.013 (95% Bayesian credible interval, -0.147 to 0.116) among those with anterior basal ganglia hemorrhages. The percentage of patients who had died by 30 days was 9.3% in the surgery group and 18.0% in the control group. Five patients (3.3%) in the surgery group had postoperative rebleeding and neurologic deterioration. Conclusions: Among patients in whom surgery could be performed within 24 hours after an acute intracerebral hemorrhage, minimally invasive hematoma evacuation resulted in better functional outcomes at 180 days than those with guideline-based medical management. The effect of surgery appeared to be attributable to intervention for lobar hemorrhages. (Funded by Nico; ENRICH ClinicalTrials.gov number, NCT02880878.).
MeSH term(s)	Humans ; Basal Ganglia Hemorrhage/mortality ; Basal Ganglia Hemorrhage/surgery ; Basal Ganglia Hemorrhage/therapy ; Bayes Theorem ; Cerebral Hemorrhage/mortality ; Cerebral Hemorrhage/surgery ; Cerebral Hemorrhage/therapy ; Minimally Invasive Surgical Procedures/methods ; Treatment Outcome ; Neuroendoscopy
Language	English
Publishing date	2024-04-05
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial
ZDB-ID	207154-x
ISSN	1533-4406 ; 0028-4793
ISSN (online)	1533-4406
ISSN	0028-4793
DOI	10.1056/NEJMoa2308440
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.34: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Stroke prevention and treatment.

Marsh, James D / Keyrouz, Salah G

Journal of the American College of Cardiology

2010 Volume 56, Issue 9, Page(s) 683–691

Abstract: The decline in stroke incidence and mortality in the U.S. over the past 20 years is reaching a plateau, and the number of strokes may actually start to increase as the population ages. However, recent clinical trials have demonstrated that there are ... ...

Abstract	The decline in stroke incidence and mortality in the U.S. over the past 20 years is reaching a plateau, and the number of strokes may actually start to increase as the population ages. However, recent clinical trials have demonstrated that there are numerous opportunities to improve stroke prevention strategies and also opportunities to effectively intervene in and treat acute strokes. For patients with diabetes and for those with prior strokes or transient ischemic attacks, it has become evident that aggressive low-density lipoprotein lowering with statin medications will decrease the risk for total and fatal strokes. Optimal anticoagulation and antiplatelet therapy for primary and secondary stroke prevention in atrial fibrillation is being carefully defined. With numerous novel factor Xa and direct thrombin inhibitor drugs completing phase III clinical trials, it is likely that additional oral anticoagulant drugs will be clinically available for stroke prevention soon. Additionally, a major clinical trial is nearing completion that may resolve the role of carotid stenting and carotid endarterectomy in primary and secondary stroke prevention. There are recent notable advances in the acute treatment of stroke. It is likely that the time window for thrombolysis for appropriate patients with strokes will be increased from 3 to 4.5 h, permitting the inclusion of more patients in this treatment approach. There is ongoing investigation of intra-arterial thrombolysis and of acute intra-arterial thrombus extraction for treatment of selected patients with strokes. Unlike the progress in treatment of ischemic strokes, treatment of hemorrhagic stroke is progressing more slowly.
MeSH term(s)	Anticoagulants/administration & dosage ; Atrial Fibrillation/complications ; Brain Ischemia/therapy ; Cholesterol, LDL/drug effects ; Diabetic Angiopathies/prevention & control ; Endarterectomy, Carotid ; Foramen Ovale, Patent/complications ; Heart Diseases/complications ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypertension/complications ; International Normalized Ratio ; Intracranial Hemorrhages/therapy ; Stents ; Stroke/epidemiology ; Stroke/prevention & control ; Stroke/therapy ; Thrombectomy ; Thrombolytic Therapy ; Thrombosis/complications ; United States/epidemiology ; Warfarin/administration & dosage
Chemical Substances	Anticoagulants ; Cholesterol, LDL ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Warfarin (5Q7ZVV76EI)
Language	English
Publishing date	2010-08-24
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	605507-2
ISSN	1558-3597 ; 0735-1097
ISSN (online)	1558-3597
ISSN	0735-1097
DOI	10.1016/j.jacc.2009.12.072
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1846: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 196: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Bicaudate infarcts in the setting of congenital absence of A

Tahsili-Fahadan, Pouya / Yahyavi-Firouz-Abadi, Noushin / Keyrouz, Salah G / Pestronk, Alan

Neurology. Clinical practice

2015 Volume 5, Issue 6, Page(s) 540–541

Language	English
Publishing date	2015-11-17
Publishing country	United States
Document type	Case Reports
ZDB-ID	2645818-4
ISSN	2163-0933 ; 2163-0402
ISSN (online)	2163-0933
ISSN	2163-0402
DOI	10.1212/CPJ.0000000000000163
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Cervical artery dissection: risk factors, treatment, and outcome; a 5-year experience from a tertiary care center.

Yaghi, Shadi / Maalouf, Nancy / Keyrouz, Salah G

The International journal of neuroscience

2012 Volume 122, Issue 1, Page(s) 40–44

Abstract: Background: Cervical artery dissection (CAD) is a common cause of stroke in young individuals. Risk factors, treatment, and outcome of CAD are not well established. Our aim is to identify risk factors, outcome, and discuss treatment of CAD.: Methods: ...

Abstract	Background: Cervical artery dissection (CAD) is a common cause of stroke in young individuals. Risk factors, treatment, and outcome of CAD are not well established. Our aim is to identify risk factors, outcome, and discuss treatment of CAD. Methods: We reviewed medical records of patients seen at our institution between 2004 and 2009, using ICD-9 codes for CAD, for risk factors, treatment, type, and outcome. Poor outcome was defined as modified Rankin Scale (mRS) score within 6 months of >1 or recurrent stroke or transient ischemic attack (TIA). Results: A total of 47 patients were identified. Twenty-four patients had spontaneous dissections (52%); 30 (63%) involved the carotid. As compared with spontaneous dissections, traumatic dissections occurred in younger patients (mean age 41.0 vs. 47.7 years, p = .064), were more likely to involve the vertebral artery (52% vs. 21%, p = .036, and caused less neurological deficits on presentation (48% vs. 75%, p = .075). Conversely, spontaneous dissections were more likely to occur in patients with hypertension (63% vs. 30%, p = .041) and hypercholesterolemia (46% vs. 9%, p = .008). Patients having no stroke had better outcomes (100% vs. 54%, p < .001). Anticoagulation was used in 17 patients (36%) and antiplatelets in 31 (64%). Outcome and adverse events were similar in the two groups. Conclusion: Hypertension and hypercholesterolemia were risk factors in spontaneous dissections, speaking for vascular wall abnormalities as potential contributors to pathophysiology of CAD. There was no evidence supporting one type of treatment over the other. A large ongoing prospective study should quell this controversy.
MeSH term(s)	Adult ; Arkansas/epidemiology ; Carotid Artery, Internal, Dissection/diagnosis ; Carotid Artery, Internal, Dissection/epidemiology ; Carotid Artery, Internal, Dissection/therapy ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Neck Injuries/diagnosis ; Neck Injuries/epidemiology ; Retrospective Studies ; Risk Factors ; Stroke/etiology ; Stroke/physiopathology ; Stroke/prevention & control ; Treatment Outcome ; Vertebral Artery Dissection/diagnosis ; Vertebral Artery Dissection/epidemiology ; Vertebral Artery Dissection/therapy
Language	English
Publishing date	2012-01
Publishing country	England
Document type	Journal Article
ZDB-ID	3061-2
ISSN	1563-5279 ; 1543-5245 ; 0020-7454
ISSN (online)	1563-5279 ; 1543-5245
ISSN	0020-7454
DOI	10.3109/00207454.2011.622453
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 657: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: An unusual presentation of a vein of Galen thrombosis.

Yaghi, Shadi / Amole, Adewumi / Akdol, Mehmet S / Keyrouz, Salah G

Acta neurologica Belgica

2012 Volume 112, Issue 4, Page(s) 419–420

MeSH term(s)	Cerebral Angiography ; Cerebral Veins/diagnostic imaging ; Humans ; Male ; Middle Aged ; Venous Thrombosis/diagnostic imaging
Language	English
Publishing date	2012-12
Publishing country	Italy
Document type	Case Reports ; Journal Article
ZDB-ID	127315-2
ISSN	2240-2993 ; 0300-9009
ISSN (online)	2240-2993
ISSN	0300-9009
DOI	10.1007/s13760-012-0088-z
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ui I Zs.57: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.

Keyrouz, Salah G / Diringer, Michael N

Critical care (London, England)

2007 Volume 11, Issue 4, Page(s) 220

Abstract: Vasospasm is one of the leading causes of morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). Radiographic vasospasm usually develops between 5 and 15 days after the initial hemorrhage, and is associated with clinically apparent ... ...

Abstract	Vasospasm is one of the leading causes of morbidity and mortality following aneurysmal subarachnoid hemorrhage (SAH). Radiographic vasospasm usually develops between 5 and 15 days after the initial hemorrhage, and is associated with clinically apparent delayed ischemic neurological deficits (DID) in one-third of patients. The pathophysiology of this reversible vasculopathy is not fully understood but appears to involve structural changes and biochemical alterations at the levels of the vascular endothelium and smooth muscle cells. Blood in the subarachnoid space is believed to trigger these changes. In addition, cerebral perfusion may be concurrently impaired by hypovolemia and impaired cerebral autoregulatory function. The combined effects of these processes can lead to reduction in cerebral blood flow so severe as to cause ischemia leading to infarction. Diagnosis is made by some combination of clinical, cerebral angiographic, and transcranial doppler ultrasonographic factors. Nimodipine, a calcium channel antagonist, is so far the only available therapy with proven benefit for reducing the impact of DID. Aggressive therapy combining hemodynamic augmentation, transluminal balloon angioplasty, and intra-arterial infusion of vasodilator drugs is, to varying degrees, usually implemented. A panoply of drugs, with different mechanisms of action, has been studied in SAH related vasospasm. Currently, the most promising are magnesium sulfate, 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, nitric oxide donors and endothelin-1 antagonists. This paper reviews established and emerging therapies for vasospasm.
MeSH term(s)	Angioplasty, Balloon/methods ; Calcium Channel Blockers/therapeutic use ; Cerebral Angiography ; Endothelin-1/antagonists & inhibitors ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Neuroprotective Agents/therapeutic use ; Nimodipine/therapeutic use ; Nitric Oxide Donors/therapeutic use ; Pregnatrienes/therapeutic use ; Subarachnoid Hemorrhage/complications ; Subarachnoid Hemorrhage/physiopathology ; Subarachnoid Hemorrhage/therapy ; Thrombolytic Therapy/methods ; Ultrasonography, Doppler, Transcranial ; Vasodilator Agents/therapeutic use ; Vasospasm, Intracranial/diagnosis ; Vasospasm, Intracranial/etiology ; Vasospasm, Intracranial/physiopathology ; Vasospasm, Intracranial/prevention & control
Chemical Substances	Calcium Channel Blockers ; Endothelin-1 ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Neuroprotective Agents ; Nitric Oxide Donors ; Pregnatrienes ; Vasodilator Agents ; Nimodipine (57WA9QZ5WH) ; tirilazad (YD064E883I)
Language	English
Publishing date	2007-08-20
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	2041406-7
ISSN	1466-609X ; 1364-8535
ISSN (online)	1466-609X
ISSN	1364-8535
DOI	10.1186/cc5958
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5517: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito